Biotechnology Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2882 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 6.67 USD | +0.60% | +17.02% | +71.91% | +421.09% | 532.29 M USD | ||
| 2889 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 10.81 USD | -1.10% | -5.18% | +8.21% | +159.86% | 528.50 M USD | ||
| 2895 |  CABA Cabaletta Bio, Inc. - Common Stock | 3.09 USD | -1.28% | +5.82% | +12.36% | +88.41% | 523.90 M USD | ||
| 2898 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.33 USD | -3.27% | -10.42% | -11.17% | -42.13% | 530.05 M USD | ||
| 2920 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.23 USD | -2.26% | -5.07% | +10.32% | +111.03% | 508.97 M USD | ||
| 2923 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 10.78 USD | -3.84% | -7.15% | -15.85% | -43.26% | 499.95 M USD | ||
| 2939 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.97 USD | -0.75% | -5.25% | +16.42% | +53.28% | 488.41 M USD | ||
| 2950 |  EVMN Evommune, Inc. Common Stock | 13.20 USD | -5.58% | -9.71% | +17.75% | -23.79% | 479.06 M USD | ||
| 2956 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.48 USD | -3.24% | -6.28% | -13.35% | +611.11% | 477.88 M USD | ||
| 2959 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.58 USD | -1.86% | +19.70% | +3.27% | -24.04% | 477.67 M USD | ||
| 2960 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.29 USD | -1.69% | +3.22% | +4.62% | +6.05% | 476.92 M USD | ||
| 2962 |  RZLT Rezolute, Inc. - Common Stock | 4.94 USD | -2.95% | +5.78% | -0.20% | -29.43% | 475.68 M USD | ||
| 2968 |  PBYI Puma Biotechnology Inc - Common Stock | 9.13 USD | -1.19% | +3.05% | +13.56% | +72.26% | 471.29 M USD | ||
| 2971 |  EDIT Editas Medicine, Inc. - Common Stock | 3.05 USD | -1.93% | +6.64% | +15.97% | +8.16% | 468.42 M USD | ||
| 2979 |  BNTC Benitec Biopharma Inc. - Common Stock | 13.00 USD | -3.56% | +1.40% | +12.07% | -21.73% | 446.61 M USD | ||
| 2982 |  OCGN Ocugen, Inc. - Common Stock | 1.36 USD | -2.16% | 0.00% | +8.80% | +34.65% | 461.19 M USD | ||
| 3000 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 7.00 USD | -5.28% | +4.79% | -7.53% | -21.17% | 450.38 M USD | ||
| 3015 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 12.91 USD | -2.57% | -3.73% | +2.79% | -12.18% | 441.10 M USD | ||
| 3019 |  EYPT EyePoint, Inc. - Common Stock | 5.11 USD | -3.95% | +21.96% | -59.05% | -57.42% | 440.54 M USD | ||
| 3030 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | 0.00% | +1.69% | +13.74% | -20.27% | 432.21 M USD |
News Biotechnology Stocks
Nurix Therapeutics: Roche Has Changed The Economics Of The Bull Case (NASDAQ:NRIX)
Should You Buy Moderna Stock Following Its Cancer Breakthrough?
Crude Oil Down 3%; XPeng Shares Fall After Q2 Results - XPeng (NYSE:XPEV), Expion360 (NASDAQ:XPON)
Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy
Moleculin Biotech (MBRX) Upgraded to Buy: Here's Why
This Darden Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - Darden Restaurants (NYSE:DRI), Ja
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |